Maximum quantity allowed is 999
CAS RN: 34183-22-7 | Product Number: P2301
Propafenone Hydrochloride

Purity: >98.0%(T)(HPLC)
- 1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-1-propanone Hydrochloride
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
1G |
₹7,400.00
|
2 | ≥40 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | P2301 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__1H__2__7NO__3·HCl = 377.91 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container ![]() |
1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 34183-22-7 |
Related CAS RN ![]() |
54063-53-5 |
Reaxys Registry Number | 4343069 |
PubChem Substance ID | 253660866 |
Merck Index (14) | 7794 |
MDL Number | MFCD00079243 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 171.0 to 175.0 °C |
NMR | confirm to structure |
Melting Point | 173 °C |
Maximum Absorption Wavelength | 303 nm (MeOH) |
Solubility (soluble in) | Methanol |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
RTECS# | UH2833000 |
References
- Propafenone (a review on the pharmacology of the antiarrhythmic agent propafenone in humans and laboratory animals.)
- Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias (a review)
- Potassium channel blocking properties of propafenone in rabbit atrial myocytes
- Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography-electrospray ionization mass spectrometry
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.